Molecular and cellular processes disrupted in the early postnatal Down syndrome prefrontal cortex
Authors:
- Ryan D. RisgaardRRRyan D. Risgaard
- Kalpana Hanthanan ArachchilageKAKalpana Hanthanan Arachchilage
- Sara A. KnaackSKSara A. Knaack
- Masoumeh HosseiniMHMasoumeh Hosseini
- Rachel J. ChenRCRachel J. Chen
- Pubudu KumaragePKPubudu Kumarage
- Xiang HuangXHXiang Huang
- Jie ShengJSJie Sheng
- Carlos J. WangCWCarlos J. Wang
- Elisa GiustiEGElisa Giusti
- Shuang LiuSLShuang Liu
Top Cited Papers
- 23 April 2026
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 392 (6796) , eaea1549
Abstract
Down syndrome is a genetic condition that causes intellectual disability and is characterized by early-onset delays in motor, cognitive, and language development. The molecular mechanisms underlying these neurodevelopmental impairments remain poorly understood. We used single-nucleus multiomic sequencing to simultaneously profile gene expression and chromatin accessibility in the Down syndrome prefrontal cortex during early postnatal development, a critical period for synaptogenesis, neural maturation, and developmental neuroimmune interactions. Our findings reveal widespread dysregulation of chromatin accessibility and gene expression, with deficits spanning metabolic and synaptic pathways, oligodendrocyte lineage progression, and a pronounced neuroinflammatory signature. We present a molecular atlas of Down syndrome neuropathology at a critical stage of brain development, highlighting convergent neurodevelopmental and neurodegenerative pathways and informing potential targeted therapies for Down syndrome–associated neuroinflammation.Keywords
All Related Versions
Funding Information
- National Institutes of Health (1R01HD106197)
- National Institutes of Health (R01AG067025)
- National Institutes of Health (RF1MH128695)
- National Institutes of Health (1F30MH140382-01)
- National Institutes of Health (T32 GM140935)
- National Institutes of Health (P50HD105353)
- National Institutes of Health (1R01HD106197)
- National Institutes of Health (R01AG067025)
- National Institutes of Health (RF1MH128695)
- National Institutes of Health (1F30MH140382-01)
- National Institutes of Health (P50HD105353)
- National Institutes of Health (P30 EY016665)
- Morse Society (Fellowship)
- Morse Society Fellowship
- National Institutes of Health (T32 GM140935)
- Brain Research Foundation (BRFSG-2023-11)
- Brain Research Foundation (BRFSG-2023-11)
This publication has 111 references indexed in Scilit:
- Age of Alzheimer's disease diagnosis in people with Down syndrome and associated factors: Results from the Horizon 21 European Down syndrome consortiumAlzheimer's & Dementia, 2024
- Apoptosis in Alzheimer’s disease: insight into the signaling pathways and therapeutic avenuesApoptosis, 2023
- Exploring Epigenomic Datasets by ChIPseekerCurrent Protocols, 2022
- Association of Alzheimer Disease With Life Expectancy in People With Down SyndromeJAMA Network Open, 2022
- Role of DJ-1 in the mechanism of pathogenesis of Parkinson's diseaseJournal of Bioenergetics and Biomembranes, 2019
- Genetic causes of intellectual disability in a birth cohort: A population‐based studyAmerican Journal of Medical Genetics Part A, 2015
- Alteration of inhibitory circuits in the somatosensory cortex of Ts65Dn mice, a model for Down’s syndromeJournal of Neural Transmission, 2010
- Fetal life in Down Syndrome starts with normal neuronal density but impaired dendritic spines and synaptosomal structure2001
- Dendritic atrophy in children with Down's syndromeAnnals of Neurology, 1986
- Pyramidal cell abnormalities in the motor cortex of a child with Down's syndrome. A Golgi studyJournal of Comparative Neurology, 1976